A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine. - Wikidata - awgldk - TriplyDB

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

http://www.wikidata.org/entity/Q30424754

about

Vaccines for preventing influenza in healthy adults Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge Airborne transmission of highly pathogenic H7N1 influenza virus in ferrets Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge.Divergent H7 immunogens offer protection from H7N9 virus challenge.Preliminary success in the characterization and management of a sudden breakout of a novel H7N9 influenza A virus.African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.Considerations for the rapid deployment of vaccines against H7N9 influenza.Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge.Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus Refining the approach to vaccines against influenza A viruses with pandemic potential.RIG-I ligand enhances the immunogenicity of recombinant H7HA protein An overview of the regulation of influenza vaccines in the United States.Antigenic Fingerprinting of Antibody Response in Humans following Exposure to Highly Pathogenic H7N7 Avian Influenza Virus: Evidence for Anti-PA-X Antibodies.Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.Induction of a robust immunity response against novel duck reovirus in ducklings using a subunit vaccine of sigma C protein A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.Preparation and evaluation of goose reovirus inactivated vaccine A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets.An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.Sample sizes in dosage investigational clinical trials: a systematic evaluation Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus

P2860

Q24197955-867B009B-6FBC-42E5-8EE9-DB93F41B6883 Q27300233-1FC1EA68-D8EB-4062-8EDB-A2378C0E2903 Q28387714-C8C53B1C-EF6D-40AC-BB41-05D7743806BF Q30151798-EC896724-77C0-484F-914A-41663AF0A881 Q30151873-5B6CBDD1-3274-4796-A368-9C6B1301E1D4 Q30201991-25683AD6-2729-42F7-AFEB-678D7A6D4DAF Q30204154-A54B1323-5EC0-4520-A655-FAF1219F2D9E Q30355863-86C8AB88-9304-4DA5-93C3-6F2584B077CF Q30358196-FBC84D25-B1FE-46CD-8C22-75615E3BC14E Q30358886-DCE2C76A-7201-4F56-ACAC-741B782BB9EC Q30362332-F3711147-C1CC-4A07-89DD-0E9B88524D0D Q30362811-46FDF1E4-267F-4240-81BF-0DB154CC80B7 Q30364635-D7E7CD46-6819-4111-AD87-FB0AA74723C8 Q30366722-10D98AC8-6086-4E22-9732-BB7825315A82 Q30368474-716A28DD-DCFD-46CF-8DC1-BD3DB75DB429 Q30368929-2C10E9F0-87E1-4F67-A1A8-BB0E10C1139F Q30369548-8D6562EA-3BCF-4681-82B0-7066A965BD82 Q30372696-45419573-929A-4348-848B-147E70DC82A5 Q30375164-D4349A50-BEC4-46FB-B738-915AD1DCD73A Q30375380-62222D69-680E-4279-A5BE-0ABD7B58EA12 Q30380945-B1D81138-8144-4F55-A4A2-AB3EA9BA6DB8 Q30381595-BE7A6003-3B44-4570-97BF-DA0A6493F4C6 Q30387227-9C2ED35F-3035-428D-ACD7-4BA7B03459EF Q30390639-703CA0F6-1C60-4AA2-94E6-796F1AF7441C Q30391721-BAFC1202-CEC2-4E0C-AF9E-7793CA462CF6 Q30392895-50A8373D-354D-4E88-898E-399BCFDE4CD8 Q30397672-95241B70-E528-4731-BC75-31CDEF9ADE16 Q30424758-336775C2-23FF-4496-9CA1-B6C7811043A6 Q30432514-2F0DB516-689A-4697-A5F1-42A896C5E587 Q30832016-85D9F53B-A9BB-4EE0-A521-F9CF8DD44486 Q33683108-7780C975-6E57-4145-BA56-B78A64FB46D9 Q33883778-DD7B09D7-A818-4328-90A1-E8D57FAEBE90 Q33931916-FE7D46BF-568F-456C-9B7F-8DDD9D2A619F Q34057737-D6732A28-B022-4AC4-8A54-5617016C2059 Q34960467-A00B0353-CF8E-426B-8DA5-2E378A2DD898 Q35550576-4A66D07E-E56C-4D26-B215-3128451B9E00 Q35787563-55F069B6-BD39-4ADE-80C2-4ED1679A1FD4 Q35919479-57F0B4C2-2DCB-46C0-B9E5-5600C7CA0F85 Q35990859-BD5B957C-8EF3-4FC6-95AE-C8A8B73BD41D Q36037316-EE193EA6-0B75-4079-8D41-6C0EC5C9D052

P2860

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

http://www.wikidata.org/entity/Q30424754

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

@ast

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

@en

type

label

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

@ast

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

@en

prefLabel

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

@ast

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

@en

P1433

Q30424754-61D6BF1A-236E-4CD9-A60C-AD596E5011B5

P1476

Q30424754-5526E061-BFE0-474F-AF11-2F976168E92B

P2093

Q30424754-1E9C74BA-7AFE-4E94-BB9A-BA5ACACD298A

Q30424754-294BB388-2A46-494C-8C5C-8587FB63751F

Q30424754-BCF4F1C0-CB0C-46DF-A53F-8FBF1CCAFB03

Q30424754-E2D5BFEF-C1B9-4B4C-9CF5-B734C3B30C48

P2860

Q30424754-06D5AA65-6264-4910-B2D0-7CC89ECC3700

Q30424754-104C5B29-250E-48B4-99B3-95261018AE5F

Q30424754-1116F636-C113-40F5-8182-10C0C5011AD6

Q30424754-2DB9DBAA-BDB6-4F71-8155-E1C813BCEA73

Q30424754-2DCB8DA8-6796-4511-8591-706351520D37

Q30424754-32321E44-4A8A-43B8-A0F0-300C43589546

Q30424754-3457FE9E-73E4-477E-8F85-DF0FEFF1B8D9

Q30424754-38E23BFC-784B-427A-BC35-50C1A8B85D53

Q30424754-3930C675-507F-4C37-BDD9-0FCF08468DE3

Q30424754-3AE35F3B-5AD3-4AB5-92E2-D5B1EF65FD0D

P304

Q30424754-2BAEDAE5-1397-4584-AD35-CF76E6AD45CD

P31

Q30424754-0505823E-7030-4B54-9FFA-2EDB25256287

Q30424754-F9F76A78-17F4-4A66-85F7-6E2AFE9F8E33

P356

Q30424754-7A3E8C7C-C6DC-4603-AAE9-88946EE6B43E

P407

Q30424754-48E98CBD-1F1F-49CA-B348-446BD7987ED7

P433

Q30424754-01B0B767-BDD9-49C4-9C62-DA7EDBD3A172

P478

Q30424754-2BA32346-32F4-4698-B144-9D21387A011E

P577

Q30424754-8C49A3AD-4E83-47BC-AD4A-8B225E5459F6

P5875

Q30424754-AAD48278-8041-48F0-B2BC-9EFF90486DD1

P698

Q30424754-65BD34DA-286D-4E89-90B8-6C8729EB054C

P932

Q30424754-775BC0B3-CA08-46A8-B55C-5ED0BB5A9DAF

P356

JOURNAL.PONE.0049704

P1433

P1476

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.

@en

P2093

Chianti L Wade-Bowers

http://www.w3.org/2001/XMLSchema#string

Diane Niño

http://www.w3.org/2001/XMLSchema#string

Robert B Couch

http://www.w3.org/2001/XMLSchema#string

Shital M Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls

Human illness from avian influenza H7N3, British Columbia

Novel avian influenza H7N3 strain outbreak, British Columbia

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

Evolution and ecology of influenza A viruses

Update on avian influenza A (H5N1) virus infection in humans

Characterization of the 1918 influenza virus polymerase genes

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness

P304

e49704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0049704

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233915581

http://www.w3.org/2001/XMLSchema#string

P698

23239968

http://www.w3.org/2001/XMLSchema#string

P932

3519847

http://www.w3.org/2001/XMLSchema#string